Stereotaxis and MicroPort EP Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China
30 août 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to...
Stereotaxis Reports 2021 Second Quarter Financial Results
10 août 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
26 juil. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment...
Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
20 juil. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2021 First Quarter Financial Results
10 mai 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 10, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report First Quarter 2021 Financial Results on May 10, 2021
19 avr. 2021 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 19, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis CEO Invited as Keynote Speaker at Robotic Surgery & Enabling Technologies Summit 2021
12 avr. 2021 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 12, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that David Fischel,...
Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
07 avr. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health...
Stereotaxis to Establish Global Headquarters in Downtown St. Louis Globe Building
08 mars 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, March 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it will move...
Stereotaxis Reports 2020 Full Year Financial Results
25 févr. 2021 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...